REGN22530 — clinical trials using this drug

Public-registry trials using REGN22530 that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.

Trial	Sponsor	Condition	Phase	Sites
REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension	Regeneron Pharmaceuticals	Primary Open Angle Glaucoma (POAG)	PHASE1 / PHASE2	0

Registry history

First registered study	June 2026 — NCT07675824 (Regeneron Pharmaceuticals)
Registered studies matching this name	1 all-time · 0 currently recruiting

Source: ClinicalTrials.gov, the public trial registry.

Free site-risk snapshot for any of these trials

Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

← Eichor home · All tracked trials · Primary Open Angle Glaucoma (POAG) studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →